There are two types of screening programs – proactive and opportunistic. Proactive screening uses population registers to invite people to be screened at regular intervals, while opportunistic screening targets people attending health services for unrelated reasons.
The value of opportunistic chlamydia screening is being called into question.
Dr Nicola Low, an epidemiologist at the University of Berne in Switzerland argues that claims about screening are not supported by rigorous research or practice.